Ono Venture Investment
Edit

Ono Venture Investment

https://www.onoventure.com
Last activity: 14.06.2024
Active
Invests in categories: InvestmentPlatformBioTechHumanResearchScienceLifeMedTechHealthTechClinic
The Official Website of Ono Venture Investment, Inc. For access to innovative technologies/novel therapeutic drug targets and collaboratio with early stage startup companies, OVI makes a strategic investment in such startup companies with cutting-edge technologies.
News
13
Portfolio
9
Persons
1
Mentions
8
Employees: 1-10
Investment Stage: Pre-Seed; Seed; Series A; Series B; Series C

Portfolio 9

DateNameWebsiteTotal RaisedLocation
14.06.2024Mission Bi...missionbiocapital.com-United Sta...
10.11.2023Photysphotys.com$75MUnited Sta...
07.06.2023Mozart The...mozart-tx.com$80MUnited Sta...
16.03.2023Switch The...switchthera.com$75.3MUnited Sta...
-Immunitas ...immunitastx.com$97MUnited Sta...
-Mediar The...mediartx.com$105MUnited Sta...
-Casma Ther...casmatx.com$200.5MUnited Sta...
-Arbor Biot...arbor.bio$215MUnited Sta...
-Curreio, I...curreio.com-Japan, Tok...

Persons 1

DateFirst NameLast NameTitleLinkedIn
-Kousuke TaniInvestment...

News 13

DateTitleDescription
06.06.2024Ono Venture Investment Invests in Mission BioCapital Platinum Program Holdings.-
10.01.2024Ono Pharmaceutical Co., Ltd. Expands Investment in Ono Venture Investment Fund I, L.P. to US$200 Million - Double the investment scale to accelerate open innovation and make strategic investments in ...-
16.06.2023Ono Venture Investment Invests in Violet Therapeutics. (Violet Therapeutics raises $10.6 million in seed funding led by the Dementia Discovery Fund (through DDF-2) and co-led by UTEC (University of T...-
16.06.2023Ono Venture Investment Invests in Mozart Therapeutics. (Mozart Therapeutics Raises $25 Million in Expanded Series A Financing to Support Clinical Development of First-in-Class CD8 Treg Modulators for...-
-Ono Venture Investment, Inc. launches a new WebSite.-
-Ono Venture Investment makes a follow-on investment in Mediar Therapeutics. (Mediar Therapeutics Announces $105 Million Financing to Advance Portfolio of First-in-Class Fibrosis Therapies)-
-Ono Venture Investment invests in Immunitas Therapeutics. (Immunitas Therapeutics Completes $58 Million Series B Financing to Advance Pipeline into the Clinic and Expand Single Cell Analysis Drug Deve...-
-Ono Venture Investment Invests in Switch Therapeutics. (Switch Therapeutics Launches with $52 Million to Advance First-of-its-Kind RNAi Technology)-
-Ono Venture Investment Invests in Casma Therapeutics. (Casma Therapeutics Raises $46.0 M in Series C Funding)-
-Ono Venture Investment Invests in Arbor Biotechnologies. (Arbor Biotechnologies Closes $215 Million Oversubscribed Series B Financing to Advance Next Generation Precision Editing Therapeutics)-
Show more

Mentions in press and media 8

DateTitleDescription
10.01.2024Ono Pharmaceutical Co., Ltd. Expands Investment in Ono Venture Investment Fund I, L.P. to US$200 Million - Double the investment scale to accelerate open innovation and make strategic investments in ...-
16.06.2023Ono Venture Investment Invests in Violet Therapeutics. (Violet Therapeutics raises $10.6 million in seed funding led by the Dementia Discovery Fund (through DDF-2) and co-led by UTEC (University of T...-
16.06.2023Ono Venture Investment Invests in Mozart Therapeutics. (Mozart Therapeutics Raises $25 Million in Expanded Series A Financing to Support Clinical Development of First-in-Class CD8 Treg Modulators for...-
-Ono Venture Investment invests in Immunitas Therapeutics. (Immunitas Therapeutics Completes $58 Million Series B Financing to Advance Pipeline into the Clinic and Expand Single Cell Analysis Drug Deve...-
-Ono Venture Investment Invests in Switch Therapeutics. (Switch Therapeutics Launches with $52 Million to Advance First-of-its-Kind RNAi Technology)-
-Ono Venture Investment Invests in Casma Therapeutics. (Casma Therapeutics Raises $46.0 M in Series C Funding)-
-Ono Venture Investment Invests in Arbor Biotechnologies. (Arbor Biotechnologies Closes $215 Million Oversubscribed Series B Financing to Advance Next Generation Precision Editing Therapeutics)-
-Ono Venture Investment invests in Curreio. (Curreio Raises JPY310M Series A to advance Cryogenic Electron Microscopy Technology)-

Reviews 0

Sign up to leave a review

Sign up Log In